Before revision: Medicinal Use Human HGF plasmid DNA transfection of cardiomyocytes is currently being examined as a potential treatment for coronary artery disease (a major cause of Myocardial infarction (MI)), as well treatment for the damage that occurs to the heart after MI.D.M.
After revision: Medicinal use Human HGF plasmid DNA transfection of cardiomyocytes is currently being examined as a potential treatment for coronary artery disease (a major cause of Myocardial infarction (MI)), as well treatment for the damage that occurs to the heart after MI.D.M.